Widschwendter M, Daxenbichler G, Marth C, Dapunt O
Univ.-Klinik für Frauenheilkunde und Geburtshilfe, Innsbruck, Osterreich.
Gynakol Geburtshilfliche Rundsch. 1994;34(3):168-70. doi: 10.1159/000272362.
Lippman and coworkers recently reported striking response rates achieved in patients with cervical cancer using a combined treatment with 13-cis-retinoic acid and interferon-alpha. In vitro studies demonstrated a synergistic amplification of proliferation inhibition by retinoids and interferon in malignant cells. Comparing all-trans- with 9-cis-retinoic acid, the latter was more effective in inhibiting tumor cell growth and in inducing synergism with interferon-gamma. Combination of retinoic acid with interferon-gamma increased the down-regulation of specific binding sites of interferon-gamma. Expression of MHC class II antigens induced by interferon-gamma was not further enhanced by retinoic acid. These results indicate that interferon seems to modulate the retinoic acid system.
李普曼及其同事最近报告称,采用13-顺式视黄酸和α干扰素联合治疗的宫颈癌患者取得了显著的缓解率。体外研究表明,类视黄醇和干扰素在恶性细胞中对增殖抑制具有协同放大作用。比较全反式视黄酸和9-顺式视黄酸,后者在抑制肿瘤细胞生长以及与γ干扰素诱导协同作用方面更有效。视黄酸与γ干扰素联合使用增加了γ干扰素特异性结合位点的下调。视黄酸并未进一步增强由γ干扰素诱导的MHC II类抗原的表达。这些结果表明,干扰素似乎可调节视黄酸系统。